Screening Malaria-box compounds to identify potential inhibitors against SARS-CoV-2 M(pro), using molecular docking and dynamics simulation studies

Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) Main protease (M(pro)) is one of the vital drug targets amongst all the coronaviruses, as the protein is indispensable for virus replication. The study aimed to identify promising lead molecules against M(pro) enzyme through virtual screen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahamad, Shahzaib, Kanipakam, Hema, Birla, Shweta, Ali, Md Shaukat, Gupta, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584923/
https://www.ncbi.nlm.nih.gov/pubmed/33131721
http://dx.doi.org/10.1016/j.ejphar.2020.173664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584923/
https://www.ncbi.nlm.nih.gov/pubmed/33131721
http://dx.doi.org/10.1016/j.ejphar.2020.173664

Ejemplares similares